Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF14 PRAMEF1 FEM1C PRAMEF2 FBXL2 PRAMEF13	1.51e-07	82	59	6	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	PRAMEF14 PRAMEF1 FEM1C PRAMEF2 FBXL2 PRAMEF13	3.63e-07	95	59	6	GO:0140767
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.09e-05	55	59	4	GO:0042974
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGM	2.57e-05	3	59	2	GO:0008184
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGM	8.53e-05	5	59	2	GO:0004645
GeneOntologyMolecularFunction	nucleobase-containing compound transmembrane transporter activity	SIDT2 SLC35A4 ABCC11	7.08e-04	59	59	3	GO:0015932
GeneOntologyMolecularFunction	regulatory RNA binding	AGO4 MOV10L1 FGFR3	8.19e-04	62	59	3	GO:0061980
GeneOntologyBiologicalProcess	in utero embryonic development	SLIT2 KIFBP SEC24C PRAMEF14 RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 GINS1	6.61e-06	596	59	10	GO:0001701
GeneOntologyBiologicalProcess	somatic stem cell population maintenance	PRAMEF14 FGFR3 PRAMEF1 PRAMEF2 PRAMEF13	1.43e-05	108	59	5	GO:0035019
GeneOntologyBiologicalProcess	blastocyst formation	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	7.35e-05	78	59	4	GO:0001825
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP34 FBXL7 RNF19A HLTF FGFR3 FEM1C FBXL2 BIRC6 HERC2P3 SPSB3 NSMCE4A	1.17e-04	1009	59	11	GO:0070647
GeneOntologyBiologicalProcess	glycogen catabolic process	ADCY10 PYGB PYGM	1.36e-04	35	59	3	GO:0005980
GeneOntologyBiologicalProcess	glucan catabolic process	ADCY10 PYGB PYGM	1.48e-04	36	59	3	GO:0009251
GeneOntologyBiologicalProcess	blastocyst development	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13 GINS1	1.59e-04	179	59	5	GO:0001824
GeneOntologyBiologicalProcess	polysaccharide catabolic process	ADCY10 PYGB PYGM	1.75e-04	38	59	3	GO:0000272
GeneOntologyBiologicalProcess	oocyte development	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.86e-04	99	59	4	GO:0048599
GeneOntologyBiologicalProcess	protein modification by small protein conjugation	FBXL7 RNF19A HLTF FGFR3 FEM1C FBXL2 BIRC6 HERC2P3 SPSB3 NSMCE4A	2.01e-04	893	59	10	GO:0032446
GeneOntologyBiologicalProcess	post-translational protein modification	USP34 FBXL7 RNF19A HLTF FGFR3 FEM1C FBXL2 BIRC6 HERC2P3 SPSB3 NSMCE4A	2.03e-04	1074	59	11	GO:0043687
GeneOntologyBiologicalProcess	oocyte differentiation	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.16e-04	103	59	4	GO:0009994
GeneOntologyBiologicalProcess	chordate embryonic development	SLIT2 KIFBP SEC24C PRAMEF14 RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 GINS1	2.26e-04	906	59	10	GO:0043009
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	SLIT2 KIFBP SEC24C PRAMEF14 RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 GINS1	2.76e-04	929	59	10	GO:0009792
GeneOntologyBiologicalProcess	axon development	ADCY10 SLIT2 KIFBP SEMA5B FGFR3 CTNNA1 CTNNA2 GFRA3	4.61e-04	642	59	8	GO:0061564
GeneOntologyBiologicalProcess	protein ubiquitination	FBXL7 RNF19A HLTF FGFR3 FEM1C FBXL2 BIRC6 HERC2P3 SPSB3	4.62e-04	811	59	9	GO:0016567
GeneOntologyBiologicalProcess	cell morphogenesis	SHANK1 ADCY10 SLIT2 KIFBP SIDT2 AGO4 SEMA5B FGFR3 CTNNA2 GFRA3 ITPR1	5.02e-04	1194	59	11	GO:0000902
GeneOntologyBiologicalProcess	epithelial fluid transport	SLC26A6 ITPR1	5.21e-04	12	59	2	GO:0042045
GeneOntologyCellularComponent	ubiquitin ligase complex	FBXL7 RNF19A PRAMEF14 PCGF3 PRAMEF1 FEM1C PRAMEF2 FBXL2 PRAMEF13 SPSB3	4.87e-08	352	59	10	GO:0000151
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	FBXL7 PRAMEF14 PRAMEF1 FEM1C PRAMEF2 FBXL2 PRAMEF13 SPSB3	1.39e-07	212	59	8	GO:0031461
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF14 PRAMEF1 FEM1C PRAMEF2 PRAMEF13	2.11e-07	47	59	5	GO:0031462
GeneOntologyCellularComponent	intracellular protein-containing complex	FBXL7 AGO4 RNF19A PRAMEF14 PCGF3 PRAMEF1 FEM1C PRAMEF2 FBXL2 PRAMEF13 SPSB3 ITPR1	1.41e-05	972	59	12	GO:0140535
GeneOntologyCellularComponent	transferase complex	FBXL7 RNF19A PRAMEF14 PCGF3 PRAMEF1 FEM1C PRAMEF2 FBXL2 PRAMEF13 SPSB3 NSMCE4A	6.88e-05	963	59	11	GO:1990234
GeneOntologyCellularComponent	SCF ubiquitin ligase complex	FBXL7 FBXL2 SPSB3	1.02e-03	70	59	3	GO:0019005
MousePheno	increased male germ cell apoptosis	AGO4 PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 FBXO47	1.34e-06	189	42	7	MP:0014052
MousePheno	abnormal male germ cell apoptosis	AGO4 PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 FBXO47	5.83e-06	236	42	7	MP:0008280
MousePheno	abnormal male germ cell physiology	AGO4 PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 FBXO47	7.26e-06	244	42	7	MP:0020362
MousePheno	abnormal spermatogonia proliferation	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.14e-05	47	42	4	MP:0002685
MousePheno	abnormal germ cell physiology	AGO4 PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 FBXO47	1.31e-05	267	42	7	MP:0020363
MousePheno	increased circulating amylase level	SIDT2 PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.72e-05	119	42	5	MP:0008806
MousePheno	abnormal cell proliferation	TNNI3K CD8A RNF19A PRAMEF14 HLTF FGFR3 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 GINS1 GFRA3 TP53BP1	6.81e-05	1294	42	13	MP:0000350
MousePheno	increased kidney weight	PREP PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	7.00e-05	145	42	5	MP:0003917
MousePheno	azoospermia	PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 FBXO47	8.24e-05	244	42	6	MP:0005159
MousePheno	abnormal circulating amylase level	SIDT2 PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	9.89e-05	156	42	5	MP:0008804
MousePheno	absent gametes	PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 FBXO47	1.07e-04	256	42	6	MP:0001117
MousePheno	increased apoptosis	AGO4 PRAMEF14 MOV10L1 HLTF RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 FBXO47 GFRA3	1.39e-04	1008	42	11	MP:0006042
MousePheno	increased cell death	AGO4 PRAMEF14 MOV10L1 HLTF RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 FBXO47 GFRA3	1.53e-04	1019	42	11	MP:0012556
MousePheno	abnormal jejunum morphology	PRAMEF1 PRAMEF2 PRAMEF13	2.48e-04	41	42	3	MP:0004002
MousePheno	abnormal kidney weight	PREP PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.78e-04	208	42	5	MP:0002707
MousePheno	abnormal apoptosis	AGO4 PRAMEF14 MOV10L1 HLTF RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 FBXO47 GINS1 GFRA3	4.53e-04	1353	42	12	MP:0001648
MousePheno	abnormal programmed cell death	AGO4 PRAMEF14 MOV10L1 HLTF RRN3P2 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 FBXO47 GINS1 GFRA3	4.75e-04	1360	42	12	MP:0014355
MousePheno	round head	TMEM94 FGFR3	4.76e-04	11	42	2	MP:0030245
MousePheno	enlarged kidney	SLIT2 PREP PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	6.14e-04	354	42	6	MP:0003068
Domain	-	NLRP11 SLIT2 FBXL7 LRRC40 PRAMEF1 PRAMEF2 FBXL2 PRAMEF13	4.84e-06	321	56	8	3.80.10.10
Domain	L_dom-like	NLRP11 SLIT2 FBXL7 LRRC40 PRAMEF1 PRAMEF2 FBXL2 PRAMEF13	5.67e-06	328	56	8	IPR032675
Domain	PRAME_family	PRAMEF1 PRAMEF2 PRAMEF13	2.39e-05	19	56	3	IPR026271
Domain	PHOSPHORYLASE	PYGB PYGM	2.64e-05	3	56	2	PS00102
Domain	Phosphorylase	PYGB PYGM	2.64e-05	3	56	2	PF00343
Domain	Glycg_phsphrylas	PYGB PYGM	2.64e-05	3	56	2	IPR011833
Domain	Glyco_trans_35	PYGB PYGM	2.64e-05	3	56	2	IPR000811
Domain	VINCULIN_1	CTNNA1 CTNNA2	5.28e-05	4	56	2	PS00663
Domain	Vinculin_CS	CTNNA1 CTNNA2	5.28e-05	4	56	2	IPR000633
Domain	Alpha_catenin	CTNNA1 CTNNA2	5.28e-05	4	56	2	IPR001033
Domain	Vinculin	CTNNA1 CTNNA2	8.78e-05	5	56	2	PF01044
Domain	Vinculin/catenin	CTNNA1 CTNNA2	1.84e-04	7	56	2	IPR006077
Domain	LRR_6	NLRP11 FBXL7 FBXL2	6.00e-04	55	56	3	PF13516
Domain	F-box	FBXL7 FBXL2 FBXO47	1.07e-03	67	56	3	PF00646
Domain	Leu-rich_rpt	NLRP11 SLIT2 FBXL7 LRRC40 FBXL2	1.29e-03	271	56	5	IPR001611
Domain	FBOX	FBXL7 FBXL2 FBXO47	1.32e-03	72	56	3	PS50181
Domain	Leu-rich_rpt_Cys-con_subtyp	FBXL7 FBXL2	1.46e-03	19	56	2	IPR006553
Domain	LRR_CC	FBXL7 FBXL2	1.46e-03	19	56	2	SM00367
Domain	F-box_dom	FBXL7 FBXL2 FBXO47	1.48e-03	75	56	3	IPR001810
Domain	His_PPase_superfam	ACP6 PFKFB3	1.62e-03	20	56	2	IPR029033
Domain	-	ACP6 PFKFB3	1.62e-03	20	56	2	3.40.50.1240
Domain	LRR_1	SLIT2 FBXL7 LRRC40 FBXL2	4.19e-03	219	56	4	PF00560
Domain	F-box-like	FBXL7 FBXL2	7.71e-03	44	56	2	PF12937
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	USP34 RNF19A PRAMEF14 MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 ITPR1	4.17e-09	326	59	9	17015433
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	USP34 RNF19A PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13 BIRC6 SLC26A6 ITPR1	1.06e-08	363	59	9	14691545
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.24e-08	18	59	4	29731491
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.24e-08	18	59	4	23894331
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.24e-08	18	59	4	14675769
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.24e-08	18	59	4	12890732
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.84e-08	19	59	4	28604677
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.55e-08	20	59	4	26694250
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.55e-08	20	59	4	16580637
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.55e-08	20	59	4	21425410
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	5.34e-08	22	59	4	31729367
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	6.45e-08	23	59	4	19480014
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	9.20e-08	25	59	4	37451217
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	9.20e-08	25	59	4	12620990
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.09e-07	26	59	4	18500982
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.48e-07	28	59	4	25089626
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.98e-07	30	59	4	38786026
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.59e-07	32	59	4	37889087
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.76e-07	35	59	4	19389355
Pubmed	Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.16e-06	46	59	4	17287250
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.62e-06	50	59	4	31806660
Pubmed	Monomeric α-catenin links cadherin to the actin cytoskeleton.	CTNNA1 CTNNA2	2.83e-06	2	59	2	23417122
Pubmed	Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.	PYGB PYGM	2.83e-06	2	59	2	25130497
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 KIFBP FBXL7 AGO4 SEMA5B WDR90 FEM1C GINS1	3.05e-06	529	59	8	14621295
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF1 PRAMEF2 PRAMEF13	3.10e-06	17	59	3	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF1 PRAMEF2 PRAMEF13	3.10e-06	17	59	3	37781892
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	MOV10L1 PRAMEF1 PRAMEF2 PRAMEF13	3.17e-06	59	59	4	11279525
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF1 PRAMEF2 PRAMEF13	3.72e-06	18	59	3	39181896
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	ACP6 AGO4 PRAMEF14 FGFR3 PRAMEF1 PRAMEF2 PRAMEF13	7.53e-06	424	59	7	21731673
Pubmed	An autoinhibited structure of α-catenin and its implications for vinculin recruitment to adherens junctions.	CTNNA1 CTNNA2	8.48e-06	3	59	2	23589308
Pubmed	Leucine zipper domain of HIV-1 gp41 interacted specifically with alpha-catenin.	CTNNA1 CTNNA2	8.48e-06	3	59	2	11883950
Pubmed	Structure of the dimerization and beta-catenin-binding region of alpha-catenin.	CTNNA1 CTNNA2	8.48e-06	3	59	2	10882138
Pubmed	Alteration of E-cadherin and alpha N-catenin immunoreactivity in the mouse spinal cord following peripheral axotomy.	CTNNA1 CTNNA2	8.48e-06	3	59	2	9370228
Pubmed	Alpha-catenin is essential in intestinal adenoma formation.	CTNNA1 CTNNA2	8.48e-06	3	59	2	17989230
Pubmed	The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin.	CTNNA1 CTNNA2	8.48e-06	3	59	2	10420987
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 SEC24C PREP PYGB LTA4H CTNNA1 BIRC6 TP53BP1	1.41e-05	653	59	8	22586326
Pubmed	Bidirectional transcription from human LRRTM2/CTNNA1 and LRRTM1/CTNNA2 gene loci leads to expression of N-terminally truncated CTNNA1 and CTNNA2 isoforms.	CTNNA1 CTNNA2	1.69e-05	4	59	2	21708131
Pubmed	N-cadherin mediates cortical organization in the mouse brain.	CTNNA1 CTNNA2	1.69e-05	4	59	2	17222817
Pubmed	Mouse alpha N-catenin: two isoforms, specific expression in the nervous system, and chromosomal localization of the gene.	CTNNA1 CTNNA2	1.69e-05	4	59	2	8174789
Pubmed	Irbit mediates synergy between ca(2+) and cAMP signaling pathways during epithelial transport in mice.	SLC26A6 ITPR1	1.69e-05	4	59	2	23542070
Pubmed	Heterocellular interaction enhances recruitment of alpha and beta-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells.	CTNNA1 CTNNA2	1.69e-05	4	59	2	18775424
Pubmed	Differential expression of alpha-E-catenin and alpha-N-catenin in the developing cerebral cortex.	CTNNA1 CTNNA2	2.82e-05	5	59	2	16457793
Pubmed	Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule.	CTNNA1 CTNNA2	2.82e-05	5	59	2	2349235
Pubmed	Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly.	CTNNA1 CTNNA2	2.82e-05	5	59	2	16325583
Pubmed	Wnt-1-dependent regulation of local E-cadherin and alpha N-catenin expression in the embryonic mouse brain.	CTNNA1 CTNNA2	2.82e-05	5	59	2	7925023
Pubmed	The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species.	CTNNA1 CTNNA2	2.82e-05	5	59	2	2788574
Pubmed	Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation.	CTNNA1 CTNNA2	4.23e-05	6	59	2	12089526
Pubmed	The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.	CTNNA1 CTNNA2	4.23e-05	6	59	2	24080911
Pubmed	Switching of alpha-catenin from alphaE-catenin in the cortical ventricular zone to alphaN-catenin II in the intermediate zone.	CTNNA1 CTNNA2	4.23e-05	6	59	2	16185771
Pubmed	The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility.	CTNNA1 CTNNA2	4.23e-05	6	59	2	12975353
Pubmed	alphaE-catenin is not a significant regulator of beta-catenin signaling in the developing mammalian brain.	CTNNA1 CTNNA2	5.91e-05	7	59	2	18397997
Pubmed	The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin.	CTNNA1 CTNNA2	5.91e-05	7	59	2	12808048
Pubmed	Expression and cell membrane localization of catenins during mouse preimplantation development.	CTNNA1 CTNNA2	5.91e-05	7	59	2	8853988
Pubmed	The tumor-suppressor function of E-cadherin.	CTNNA1 CTNNA2	5.91e-05	7	59	2	9837810
Pubmed	The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration.	CTNNA1 CTNNA2	5.91e-05	7	59	2	12052883
Pubmed	Adhesion protein VSIG1 is required for the proper differentiation of glandular gastric epithelia.	CTNNA1 CTNNA2	5.91e-05	7	59	2	21991385
Pubmed	Functional analysis of ectodermal β-catenin during external genitalia formation.	CTNNA1 CTNNA2	7.87e-05	8	59	2	23480356
Pubmed	TGF-beta3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion.	CTNNA1 CTNNA2	7.87e-05	8	59	2	12068957
Pubmed	The genes coding for alpha and beta catenin (Catna1 and Catnb) and plakoglobin (Jup) map to mouse chromosomes 18, 9, and 11, respectively.	CTNNA1 CTNNA2	7.87e-05	8	59	2	7626889
Pubmed	Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation.	CTNNA1 CTNNA2	1.01e-04	9	59	2	28692740
Pubmed	Expression of catenins during mouse embryonic development and in adult tissues.	CTNNA1 CTNNA2	1.01e-04	9	59	2	8821035
Pubmed	NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.	CTNNA1 CTNNA2	1.01e-04	9	59	2	12695331
Pubmed	Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism.	CTNNA1 CTNNA2	1.26e-04	10	59	2	35105859
Pubmed	Alpha N-catenin deficiency causes defects in axon migration and nuclear organization in restricted regions of the mouse brain.	CTNNA1 CTNNA2	1.26e-04	10	59	2	16691566
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	PRAMEF1 PRAMEF2 PRAMEF13	1.34e-04	58	59	3	31598710
Pubmed	cDNA cloning and expression analysis of new members of the mammalian F-box protein family.	FBXL7 FBXL2	1.54e-04	11	59	2	10945468
Pubmed	The murine gene, Traube, is essential for the growth of preimplantation embryos.	FGFR3 CTNNA1	1.54e-04	11	59	2	11071758
Pubmed	Scrib is required for epithelial cell identity and prevents epithelial to mesenchymal transition in the mouse.	CTNNA1 CTNNA2	1.54e-04	11	59	2	24095903
Pubmed	Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis.	CTNNA1 CTNNA2	1.54e-04	11	59	2	21844209
Pubmed	A role for chromosomal protein HMGN1 in corneal maturation.	CTNNA1 CTNNA2	1.54e-04	11	59	2	16466397
Pubmed	Lamellipodium extension and cadherin adhesion: two cell responses to cadherin activation relying on distinct signalling pathways.	CTNNA1 CTNNA2	1.54e-04	11	59	2	14657280
Pubmed	Synergistic action of nectins and cadherins generates the mosaic cellular pattern of the olfactory epithelium.	CTNNA1 CTNNA2	1.85e-04	12	59	2	26929452
Pubmed	Mechanochemical control of epidermal stem cell divisions by B-plexins.	CTNNA1 CTNNA2	2.18e-04	13	59	2	33637728
Pubmed	Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.	PYGB PYGM	2.93e-04	15	59	2	2575583
Pubmed	Binary Fate Choice between Closely Related Interneuronal Types Is Determined by a Fezf1-Dependent Postmitotic Transcriptional Switch.	SLIT2 GFRA3	2.93e-04	15	59	2	31812516
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	AGO4 PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.09e-04	347	59	5	16033648
Pubmed	Desmoplakin is essential in epidermal sheet formation.	CTNNA1 CTNNA2	3.79e-04	17	59	2	11781569
Pubmed	A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.	KIFBP SEC24C LRRC40 FGFR3 FBXL2	3.80e-04	363	59	5	25036637
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	TNNI3K FGFR3 PCGF3 FBXL2 SPSB3	4.25e-04	372	59	5	22939624
Pubmed	PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth.	FBXL7 FBXL2	4.25e-04	18	59	2	28614300
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	CTNNA2 ITPR1	4.25e-04	18	59	2	33323119
Pubmed	Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.	SHANK1 SLIT2	4.25e-04	18	59	2	27984743
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	KIFBP SEC24C HLTF LRRC40 CTNNA1 EXOC2	4.55e-04	582	59	6	20467437
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 SEC24C PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13 TP53BP1 ITPR1	4.70e-04	1084	59	8	11544199
Pubmed	alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway.	CTNNA1 CTNNA2	4.75e-04	19	59	2	16543460
Pubmed	Development of midline cell types and commissural axon tracts requires Fgfr1 in the cerebrum.	SLIT2 FGFR3	5.27e-04	20	59	2	16309667
Pubmed	Loss of BAF Complex in Developing Cortex Perturbs Radial Neuronal Migration in a WNT Signaling-Dependent Manner.	CTNNA1 CTNNA2	5.27e-04	20	59	2	34220450
Pubmed	Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis.	CTNNA1 CTNNA2	5.82e-04	21	59	2	19129494
Pubmed	E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions.	CTNNA1 CTNNA2	5.82e-04	21	59	2	15775979
Pubmed	Modulation of apical constriction by Wnt signaling is required for lung epithelial shape transition.	CTNNA1 CTNNA2	6.39e-04	22	59	2	27913639
Pubmed	Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact.	CTNNA1 CTNNA2	7.62e-04	24	59	2	15923648
Pubmed	Defining the membrane proteome of NK cells.	AGO4 PREP HLTF PYGB LRRC40 EXOC2 BIRC6 ITPR1	7.67e-04	1168	59	8	19946888
Pubmed	Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins.	CD8A GPR88	8.28e-04	25	59	2	28154160
Pubmed	Epidermal development requires ninein for spindle orientation and cortical microtubule organization.	CTNNA1 CTNNA2	8.96e-04	26	59	2	30923192
Pubmed	αE-Catenin Is a Positive Regulator of Pancreatic Islet Cell Lineage Differentiation.	CTNNA1 CTNNA2	8.96e-04	26	59	2	28793255
Pubmed	The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.	CTNNA1 CTNNA2	8.96e-04	26	59	2	23077317
Pubmed	Analysis of a lung defect in autophagy-deficient mouse strains.	PYGB PYGM	8.96e-04	26	59	2	24275123
Pubmed	Genome-wide mapping of unselected transcripts from extraembryonic tissue of 7.5-day mouse embryos reveals enrichment in the t-complex and under-representation on the X chromosome.	PREP EXOSC5 CTNNA1 CTNNA2	9.92e-04	259	59	4	9811942
Pubmed	Expression of Robo/Slit and Semaphorin/Plexin/Neuropilin family members in the developing hypothalamic paraventricular and supraoptic nuclei.	SLIT2 SEMA5B	1.04e-03	28	59	2	18617019
Pubmed	Characterising the dynamics of placental glycogen stores in the mouse.	PYGB PYGM	1.12e-03	29	59	2	32798765
Cytoband	1p36.21	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.38e-06	63	59	4	1p36.21
Cytoband	20p11.21	PYGB GINS1	8.36e-04	33	59	2	20p11.21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	GPR3 PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	1.83e-03	681	59	5	chr1p36
Cytoband	1p31.1	TNNI3K LRRC40	3.81e-03	71	59	2	1p31.1
Cytoband	4p16.3	FGFR3 PCGF3	5.41e-03	85	59	2	4p16.3
GeneFamily	PRAME family	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	2.58e-07	24	42	4	686
GeneFamily	Glycogen phosphorylases	PYGB PYGM	1.58e-05	3	42	2	437
GeneFamily	G protein-coupled receptors, Class A orphans	GPR3 GPR171 GPR88	7.86e-04	78	42	3	262
GeneFamily	F-box and leucine rich repeat proteins	FBXL7 FBXL2	1.08e-03	21	42	2	558
Coexpression	KOHOUTEK_CCNT2_TARGETS	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	3.38e-05	81	59	4	MM938
Coexpression	KINNEY_DNMT1_METHYLATION_TARGETS	PRAMEF1 PRAMEF2 PRAMEF13	6.17e-05	34	59	3	MM955
Coexpression	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	7.14e-05	98	59	4	MM592
Coexpression	DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR	PRAMEF1 PRAMEF2 PRAMEF13 GFRA3	7.14e-05	98	59	4	MM3656
Coexpression	HUANG_GATA2_TARGETS_DN	PRAMEF14 PRAMEF1 PRAMEF2 PRAMEF13	7.14e-05	98	59	4	MM942
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP	VIPR2 CD8A RNF19A SPSB3 SLC26A6	8.61e-05	199	59	5	M8028
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN	HLTF PYGB WDR90 SLC26A6 ITPR1	8.82e-05	200	59	5	M4041
Coexpression	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP	USP34 LRRC40 FEM1C GINS1 NSMCE4A	8.82e-05	200	59	5	M6584
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NLRP11 CD8A TMEM94 MOV10L1 GPR171	1.96e-06	155	59	5	5687416773809b8c478567bc54310af102b3029a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACP6 CD8A RNF19A MOV10L1 GPR171	3.55e-06	175	59	5	06eace2e681980456299167b48bd49bcfea5e940
Drug	Gvapspat amide	PYGB PYGM ITPR1	6.98e-06	15	58	3	CID000125015
Drug	5-fluorodeoxyuridine	KIFBP ABCC11 PYGB PYGM CTNNA2	7.49e-06	106	58	5	CID000003363
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SHANK1 FBXL7 CD8A CTNNA1 SPSB3 ITPR1	1.11e-05	198	58	6	5425_UP
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGM	1.91e-05	3	58	2	CID000521488
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGM	1.91e-05	3	58	2	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGM	1.91e-05	3	58	2	CID000191554
Drug	hydan	PYGB PYGM	1.91e-05	3	58	2	CID000008360
Drug	EHMF	PYGB PYGM	1.91e-05	3	58	2	CID000033931
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGM	1.91e-05	3	58	2	CID000147839
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGM	1.91e-05	3	58	2	CID003082249
Drug	Plp 5'-mpa	PYGB PYGM	1.91e-05	3	58	2	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGM	1.91e-05	3	58	2	CID000191723
Drug	3'-FFdUrd	PYGB PYGM	1.91e-05	3	58	2	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGM	1.91e-05	3	58	2	CID000119518
Drug	AC1L8XK3	PYGB PYGM	1.91e-05	3	58	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGM	1.91e-05	3	58	2	CID000446801
Drug	NSC758405	PYGB PYGM	1.91e-05	3	58	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGM	1.91e-05	3	58	2	CID000151920
Drug	riboflavin tetraacetate	PYGB PYGM	1.91e-05	3	58	2	CID000094186
Drug	pyridoxal phosphoglucose	PYGB PYGM	1.91e-05	3	58	2	CID000196007
Drug	2,5-dimethyl-3-furanone	PYGB PYGM	1.91e-05	3	58	2	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGM	1.91e-05	3	58	2	CID000011459
Drug	galocitabine	PYGB PYGM	3.81e-05	4	58	2	CID000065950
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGM	3.81e-05	4	58	2	CID000189134
Drug	AC1LAMW2	PYGB PYGM	3.81e-05	4	58	2	CID000491364
Drug	FdUrd-C8	PYGB PYGM	3.81e-05	4	58	2	CID000094262
Drug	Mem-CC	PYGB PYGM	3.81e-05	4	58	2	CID003081269
Drug	5-deoxyribose-1-phosphate	PYGB PYGM	3.81e-05	4	58	2	CID000135786
Drug	ingliforib	PYGB PYGM	3.81e-05	4	58	2	CID006451325
Drug	uric acid riboside	PYGB PYGM	3.81e-05	4	58	2	CID000164933
Drug	pseudo-dl-glucose	PYGB PYGM	3.81e-05	4	58	2	CID000125259
Drug	BCIp4A	PYGB PYGM	3.81e-05	4	58	2	CID000192417
Drug	pyridoxal diphosphate	PYGB PYGM	3.81e-05	4	58	2	CID000125696
Drug	3'-chloromethotrexate	PYGB PYGM	3.81e-05	4	58	2	CID000097703
Drug	heptulose-2-P	PYGB PYGM	6.35e-05	5	58	2	CID000124823
Drug	m-anisidine	PYGB PYGM	6.35e-05	5	58	2	CID000010824
Drug	6-FPLP	PYGB PYGM	6.35e-05	5	58	2	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGB PYGM	6.35e-05	5	58	2	CID009576855
Drug	2-hydroxypropylphosphonate	PYGB PYGM	6.35e-05	5	58	2	CID000441028
Drug	DHPBU	PYGB PYGM	6.35e-05	5	58	2	CID000125914
Drug	6-FDPL	PYGB PYGM	6.35e-05	5	58	2	CID000129578
Drug	5'-isobutylthioinosine	PYGB PYGM	6.35e-05	5	58	2	CID003080910
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGB PYGM	6.35e-05	5	58	2	CID003082179
Drug	GlcMan	PYGB PYGM	6.35e-05	5	58	2	CID000152120
Drug	U66985	PYGB PYGM	6.35e-05	5	58	2	CID000127224
Drug	indirubin-5-sulphonate	PYGB PYGM	6.35e-05	5	58	2	CID005288641
Drug	AC1O3M08	PYGB PYGM	6.35e-05	5	58	2	CID006331955
Drug	AC1LCUXJ	PYGB PYGM	6.35e-05	5	58	2	CID000656425
Drug	6-amino-5-bromouracil	PYGB PYGM	6.35e-05	5	58	2	CID000080578
Drug	etafenone	PYGB PYGM	6.35e-05	5	58	2	CID000003275
Drug	ddEtUrd	PYGB PYGM	6.35e-05	5	58	2	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGB PYGM	6.35e-05	5	58	2	CID000125618
Drug	CV-araU	PYGB PYGM	9.50e-05	6	58	2	CID006441877
Drug	2-thiothymidine	PYGB PYGM	9.50e-05	6	58	2	CID003005944
Drug	Carbocyclic Bvdc	PYGB PYGM	9.50e-05	6	58	2	CID006438602
Drug	DNPP	PYGB PYGM	9.50e-05	6	58	2	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGB PYGM	9.50e-05	6	58	2	CID000082693
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGB PYGM	9.50e-05	6	58	2	CID000152984
Drug	EdUMP	PYGB PYGM	9.50e-05	6	58	2	CID003085112
Drug	5'-deoxy-5'-chloroformycin	PYGB PYGM	9.50e-05	6	58	2	CID000126430
Drug	NSC-97433	PYGB PYGM	9.50e-05	6	58	2	CID000001803
Drug	5-n-propylthioadenosine	PYGB PYGM	9.50e-05	6	58	2	CID000656428
Drug	AzddCyd	PYGB PYGM	9.50e-05	6	58	2	CID000451374
Drug	5-Ffdru	PYGB PYGM	9.50e-05	6	58	2	CID000065561
Drug	AR-L57	PYGB PYGM	9.50e-05	6	58	2	CID000156890
Drug	Carbocyclic Ivdu	PYGB PYGM	9.50e-05	6	58	2	CID006439191
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	NPY5R FBXL7 CTNNA1 PFKFB3 ITPR1	1.23e-04	190	58	5	5926_DN
Drug	alpha-(fluoromethyl)dehydroornithine	PYGB PYGM	1.33e-04	7	58	2	CID006439607
Drug	6-fluoropyridoxal	PYGB PYGM	1.33e-04	7	58	2	CID003080803
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGB PYGM	1.33e-04	7	58	2	CID000356019
Drug	heptenitol	PYGB PYGM	1.33e-04	7	58	2	CID000188267
Drug	AC1L3372	PYGB PYGM	1.33e-04	7	58	2	CID000108025
Drug	1 Gpt	PYGB PYGM	1.33e-04	7	58	2	CID000101247
Drug	formycins	PYGB PYGM	1.33e-04	7	58	2	CID000512867
Drug	Promonta	PYGB PYGM	1.33e-04	7	58	2	CID000108494
Drug	5'-methylthioinosine	PYGB PYGM	1.33e-04	7	58	2	CID000161214
Drug	hydantocidin	PYGB PYGM	1.33e-04	7	58	2	CID000125429
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A	SIDT2 FBXL7 RNF19A ZNF277 ITPR1	1.39e-04	195	58	5	3580_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	GPR3 FBXL7 CD8A CTNNA1 SPSB3	1.42e-04	196	58	5	3400_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; HL60; HT_HG-U133A	VIPR2 FBXL7 PYGB PCGF3 SPSB3	1.46e-04	197	58	5	6161_DN
Drug	Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	GPR3 FBXL7 CTNNA2 PCGF3 ITPR1	1.46e-04	197	58	5	4730_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A	RIN1 FBXL7 AGO4 PYGB PCGF3	1.56e-04	200	58	5	1872_DN
Drug	1,2-dimethoxyethane	SEC24C PYGB PYGM	1.68e-04	42	58	3	CID000008071
Drug	11-keto-beta-boswellic acid	PREP LTA4H	1.77e-04	8	58	2	CID006918114
Drug	AC1NUVX5	PYGB PYGM	1.77e-04	8	58	2	CID005461894
Drug	6-methylpurine	PYGB PYGM	1.77e-04	8	58	2	CID005287547
Drug	amorphin	PYGB PYGM	1.77e-04	8	58	2	CID000122792
Drug	Etafenone [inn]	PYGB PYGM	1.77e-04	8	58	2	CID000066659
Drug	AC1NBU2S	VIPR2 PYGB PYGM ITPR1	2.27e-04	117	58	4	CID004473765
Drug	6-benzyl-2-thiouracil	PYGB PYGM	2.27e-04	9	58	2	CID000685814
Drug	5'-methylthiotubercidin	PYGB PYGM	2.27e-04	9	58	2	CID000188350
Drug	alpha-maltosyl fluoride	PYGB PYGM	2.27e-04	9	58	2	CID000194237
Drug	5-Iodoribose 1-phosphate	PYGB PYGM	2.27e-04	9	58	2	CID003035973
Drug	5'-iodo-5'-deoxyadenosine	PYGB PYGM	2.27e-04	9	58	2	CID000107502
Drug	8-azidoadenosine 5'-monophosphate	PYGB PYGM	2.83e-04	10	58	2	CID000124726
Drug	2,6-dihydroxypyridine	PYGB PYGM	2.83e-04	10	58	2	CID000069371
Drug	6-methyluridine	PYGB PYGM	2.83e-04	10	58	2	CID000092887
Drug	UDP-pyridoxal	PYGB PYGM	2.83e-04	10	58	2	CID000126789
Drug	N-nitrosomorpholine	MOV10L1 PYGB PYGM	3.17e-04	52	58	3	CID000006046
Drug	glucosyl fluoride	PYGB PYGM	3.46e-04	11	58	2	CID000150967
Disease	lysophosphatidylethanolamine 18:0 measurement	SIDT2 FBXL7	3.53e-04	15	55	2	EFO_0010367
Disease	insular cortex volume measurement	SLIT2 FBXO47	8.42e-04	23	55	2	EFO_0010309
Disease	Strabismus	ABCC11 EXOC2	1.34e-03	29	55	2	HP_0000486
Disease	internet addiction disorder	NPY5R GFRA3	1.74e-03	33	55	2	EFO_0803368
Disease	lysophosphatidylethanolamine 18:1 measurement	SIDT2 NPY5R	1.84e-03	34	55	2	EFO_0010368

Protein segments in the cluster

Peptide	Gene	Start	Entry
CRYNLACHRLETLLQ	BIRC6	1926	Q9NR09
LLLSLVITLYCNHRN	CD8A	196	P01732
VITLYCNHRNRRRVC	CD8A	201	P01732
LQLLTYQLCHTYVRC	AGO4	781	Q9HCK5
YQSLCRLSRCLLLNS	ADCY10	1336	Q96PN6
INAHITCRLCSGYLI	PCGF3	11	Q3KNV8
YLFSQCQAIHCRAIL	LTA4H	131	P09960
LQCLAARVIVNHRIY	FEM1C	586	Q96JP0
YCHELVSLNLQSCSR	FBXL2	206	Q9UKC9
HCLVALNRYLLITRA	GPR88	131	Q9GZN0
VQVLRYCCLLAHSIS	MOV10L1	1041	Q9BXT6
TIYRQLHSLCQRRAL	MTIF2	16	P46199
HICRLCYRVLRHSQQ	ITPR1	551	Q14643
DYCCHLRTLKLSVQR	NLRP11	586	P59045
LLIVLSNCCYLERHT	EXOC2	711	Q96KP1
ICHQAVLRCLLAYFL	PFKFB3	386	Q16875
DRCLQLTHSCKIYRI	GPR171	111	O14626
ARYLQVLHCCSLNRD	ABCC11	601	Q96J66
CSLRHFACEQNLLSR	EXOSC5	26	Q9NQT4
LQCHQAHLTRLCSEY	IP6K3	176	Q96PC2
QLYAQICRIVCRHAQ	GPR3	211	P46089
IACVRSNFLVLCYLH	PREP	341	P48147
RIALYCHQLNICSKV	CTNNA2	781	P26232
QRIALYCHQLNICSK	CTNNA1	781	P35221
CQRHVCLRQLLTFFE	GFRA3	191	O60609
HCTQLTHLYLRRCVR	FBXL7	296	Q9UJT9
HRVYNFLCELTNLCR	FBXO47	181	Q5MNV8
RLRQICCHTYLLTNA	HLTF	711	Q14527
AYSCRQRLTQRVLCH	FGFR3	106	P22607
RLRIHNLALNCCTQL	SEC24C	821	P53992
RRYRLSHDCISLCIQ	KIFBP	126	Q96EK5
RNLKCLYLQHNELTC	LRRC40	151	Q9H9A6
VYQRRGLVHLCCSKL	PRAMEF13	171	Q5VWM6
LVQLICAYCHTRDIL	RIN1	141	Q13671
RRILHVLYTDCIRQC	SIDT2	666	Q8NBJ9
VYQRRGLVHLCCSKL	PRAMEF14	171	Q5SWL7
QCSRARAYALLLQHL	SLC26A6	61	Q9BXS9
NLISNRHFKLVYCIC	NPY5R	396	Q15761
LCRQIRHQYRALINS	NSMCE4A	81	Q9NXX6
VYQRRGLVHLCCSKL	PRAMEF1	171	O95521
SLQYLCCHRLRQLRP	SPSB3	276	Q6PJ21
LCQIERYCRQCHLTT	HERC2P3	136	Q9BVR0
VYQRRGLVHLCCSKL	PRAMEF2	171	O60811
LHICALYNKETCARI	SHANK1	351	Q9Y566
LNRCYGHLKSIRLCA	WDR90	156	Q96KV7
RQLLNCLHVITLYNR	PYGM	576	P11217
HHRSCVDCLRQYLRI	RNF19A	151	Q9NV58
RLCRFSDHLCNIALQ	TMEM94	601	Q12767
RQLLNCLHVVTLYNR	PYGB	576	P11216
TAVLYCLCLRHRLSV	SLC35A4	126	Q96G79
VLTSLAYCLHQRRVA	ACP6	16	Q9NPH0
LRTFRLHSNNLYCDC	SLIT2	201	O94813
LTLAVYLSCQHCQRQ	SEMA5B	1051	Q9P283
QCLLIADQHCRTRKY	TP53BP1	1801	Q12888
CTIECYVHNLLRISV	RRN3P2	196	A6NIE6
IILCLFRKLHCTRNY	VIPR2	146	P41587
LVNFIRRQVHQCRCY	ZNF277	346	Q9NRM2
TCNLIFSLCRYNNRL	USP34	2566	Q70CQ2
HCSLLRNRRCTVAYL	GINS1	66	Q14691
NYRTENGLSLLHLCC	TNNI3K	61	Q59H18